$12.03
-0.27-2.2%
Last update: Oct 30, 4:00 PM
Ardent Health Inc
ARDTNYSE
Ardent Health (ARDT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ardent Health (ARDT) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $0.78 - $1.15, compared to a consensus EPS estimate of $1.22. Ardent Health also guided revenue in the range of $6.4B - $6.7B for the period.
Compared to prior guidance, Ardent Health lowered its EPS outlook from a previous range of $0.9 - $1.27. On the revenue side, the company maintained its revenue forecast from a prior range of $6.4B - $6.7B.
Ardent Health has issued 9 guidance updates between August 14, 2024 and August 4, 2026. During this period, the company raised its outlook 2 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.22 | $0.18 | $0.35 | $0.42 |
| Actual | $0.12 | $0.28 | $0.32 | $-0.17 |
| Surprise | -45.5% | +55.6% | -8.57% | -140.5% |
| Revenue | ||||
| Estimate | $1.63B | $1.58B | $1.63B | $1.55B |
| Actual | $1.62B | $1.60B | $1.60B | $1.58B |
| Surprise | -0.49% | +1.56% | -1.82% | +1.76% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.24 | $0.34 | $0.25 | $0.31 |
| Revenue | ||||
| Consensus | $1.61B | $1.64B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.12 | $0.22 | -45.5 % |
| Q1 | May 5, 2026 | $0.28 | $0.18 | 55.6 % |
| Q4 | Mar 4, 2026 | $0.32 | $0.35 | -8.57 % |
| Q3 | Nov 12, 2025 | $-0.17 | $0.42 | -140.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $1.62B | $1.63B | -0.49 % |
| Q1 | May 5, 2026 | $1.60B | $1.58B | 1.56 % |
| Q4 | Mar 4, 2026 | $1.61B | $1.63B | -1.82 % |
| Q3 | Nov 12, 2025 | $1.58B | $1.55B | 1.76 % |
